Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: the injection site started to heat up and felt itchy; the injection site started to heat up and felt itchy; The injection site was sore with a large red, hot, itchy rash, about 6 inch in diameter around injection site; The injection site was sore with a large red, hot, itchy rash, about 6 inch in diameter around injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (the injection site started to heat up and felt itchy), INJECTION SITE PRURITUS (the injection site started to heat up and felt itchy), INJECTION SITE ERYTHEMA (The injection site was sore with a large red, hot, itchy rash, about 6 inch in diameter around injection site) and INJECTION SITE RASH (The injection site was sore with a large red, hot, itchy rash, about 6 inch in diameter around injection site) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034C21A and 042B21A) for COVID-19 vaccination.     The patient's past medical history included Rash (broke into rash from drink colored with red food dye) in 1986 and Itchy throat (lingonberry sauce; throat started to swell and itch) in 2010. Concurrent medical conditions included Egg allergy (minor allergy to egg), Hypersensitivity reaction, Hay fever and Urticaria. Concomitant products included SERTRALINE for Anxiety.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form once. On 20-May-2021 at 12:30 PM, the patient experienced INJECTION SITE WARMTH (the injection site started to heat up and felt itchy), INJECTION SITE PRURITUS (the injection site started to heat up and felt itchy), INJECTION SITE ERYTHEMA (The injection site was sore with a large red, hot, itchy rash, about 6 inch in diameter around injection site) and INJECTION SITE RASH (The injection site was sore with a large red, hot, itchy rash, about 6 inch in diameter around injection site). On 23-May-2021, INJECTION SITE WARMTH (the injection site started to heat up and felt itchy), INJECTION SITE PRURITUS (the injection site started to heat up and felt itchy), INJECTION SITE ERYTHEMA (The injection site was sore with a large red, hot, itchy rash, about 6 inch in diameter around injection site) and INJECTION SITE RASH (The injection site was sore with a large red, hot, itchy rash, about 6 inch in diameter around injection site) had resolved with sequelae.            No treatment information was reported. After 30 minutes to 1 hour of receiving second dose, the reactions occurred. The patient recovered with residual effects of occasional itching at site. The itching prolonged for over a month.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow-up information included no new information. On 13-Aug-2021: Follow up received on 13-AUG-2021: Reporter address information was updated. Suspected drug second dose, added concomitant medication, events of injection site rash, warmth, redness and itching were also added.